- Home
- LXEO vs EURK Comparison
LXEO vs EURK Comparison
Compare LXEO & EURK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- EURK
- Stock Information
- Founded
- LXEO 2017
- EURK 2023
- Country
- LXEO United States
- EURK Hong Kong
- Employees
- LXEO N/A
- EURK N/A
- Industry
- LXEO
- EURK
- Sector
- LXEO
- EURK
- Exchange
- LXEO Nasdaq
- EURK NYSE
- Market Cap
- LXEO 93.9M
- EURK 80.0M
- IPO Year
- LXEO 2023
- EURK 2024
- Fundamental
- Price
- LXEO $2.78
- EURK $10.38
- Analyst Decision
- LXEO Strong Buy
- EURK
- Analyst Count
- LXEO 6
- EURK 0
- Target Price
- LXEO $18.50
- EURK N/A
- AVG Volume (30 Days)
- LXEO 984.8K
- EURK 38.0K
- Earning Date
- LXEO 05-12-2025
- EURK 01-01-0001
- Dividend Yield
- LXEO N/A
- EURK N/A
- EPS Growth
- LXEO N/A
- EURK N/A
- EPS
- LXEO N/A
- EURK N/A
- Revenue
- LXEO N/A
- EURK N/A
- Revenue This Year
- LXEO N/A
- EURK N/A
- Revenue Next Year
- LXEO N/A
- EURK N/A
- P/E Ratio
- LXEO N/A
- EURK $61.54
- Revenue Growth
- LXEO N/A
- EURK N/A
- 52 Week Low
- LXEO $1.45
- EURK $10.03
- 52 Week High
- LXEO $19.50
- EURK $10.41
- Technical
- Relative Strength Index (RSI)
- LXEO 45.92
- EURK N/A
- Support Level
- LXEO $2.51
- EURK N/A
- Resistance Level
- LXEO $2.91
- EURK N/A
- Average True Range (ATR)
- LXEO 0.38
- EURK 0.00
- MACD
- LXEO -0.04
- EURK 0.00
- Stochastic Oscillator
- LXEO 33.62
- EURK 0.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About EURK EUREKA ACQUISITION CORP
Eureka Acquisition Corp is a newly incorporated blank check company.